Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003-2006

Internal Medicine Journal

Volumn 42, Issue 5, 2012, Pages 505-512

  Hewagama, S ^a   Spelman, T ^b   Einsiedel, L J ^a,b  

^a ALICE SPRINGS HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Bacteraemia; Indigenous health; Methicillin resistance; Staphylococcus aureus

Indexed keywords

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTERIAL ARTHRITIS; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; FEMALE; GASTROENTERITIS; HOSPITAL; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MEDICAL RECORD; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; OSTEOMYELITIS; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SCABIES; SKIN ABSCESS; STAPHYLOCOCCAL BACTEREMIA; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84861426039     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02449.x     Document Type: Article

References (34)

1. Australian Institute of Health and Welfare and Australian Bureau of Statistics. The health and welfare of Australia's Aboriginal and Torres Strait Islander Peoples 2008. Canberra: ABS, 2009. (AIHW Cat. No. IHW 21; ABS Catalogue No. 4704.0). [cited 2009 Aug 5] Available from URL:
2. Einsiedel LJ, Fernandes LA, Woodman RJ. Racial disparities in infection-related mortality at Alice Springs Hospital, Central Australia, 2000-2005. Med J Aust 2008; 188: 568-71.
3. Einsiedel LJ, Woodman RJ. Two nations: racial disparities in bloodstream infections recorded at Alice Springs Hospital, Central Australia, 2001-2005. Med J Aust 2008; 192: 567-71.
4. Mitchell DH, Howden BP. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med J 2005; 35 (Suppl 2): S17-24.
5. Smith IM, Vickers AB. Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955). Lancet 1960; 1: 1318-22.
6. Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC etal. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 2009; 199: 1461-70.
7. Johnsson D, Molling P, Stralin K, Soderquist B. Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin Microbiol Infect 2004; 10: 884-9.
8. Tong SY, McDonald MI, Holt DC, Currie BJ. Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clin Infect Dis 2008; 46: 1871-8.
9. Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, Nimmo GR etal. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009; 191: 368-73.
10. Coombs GW, Pearson JC, O'Brien FG, Murray RJ, Grubb WB, Christiansen KJ. Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis 2006; 12: 241-7.
11. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR etal. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008; 46: 799-806.
12. Nimmo GR, Coombs GW, Pearson JC, O'Brien FG, Christiansen KJ, Turnidge JD etal. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184: 384-8.
13. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D etal. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194: 1761-70.
14. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M etal. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-9.
15. Murray RJ, Lim TT, Pearson JC, Grubb WB, Lum GD. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia. Int J Infect Dis 2004; 8: 275-83.
16. Tong SY, Lilliebridge RA, Bishop EJ, Cheng AC, Holt DC, McDonald MI etal. Clinical correlates of panton-valentine leukocidin (PVL), PVL isoforms, and clonal complex in the staphylococcus aureus population of northern Australia. J Infect Dis 2010; 202: 760-9.
17. Stevens CL, Ralph A, McLeod JE, McDonald MI. Community-acquired methicillin-resistant Staphylococcus aureus in Central Australia. Commun Dis Intell 2006; 30: 462-6.
18. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP etal. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
19. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
20. Turnidge JD, Nimmo GR, Pearson J, Gottlieb T, Collignon PJ. Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell 2007; 31: 398-403.
21. Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R etal. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001; 31: 97-103.
22. Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JC, Grundmann H. Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 2005; 11: 1798-9.
23. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11: 554-61.
24. O'Brien JM, Jr, Lu B, Ali NA, Martin GS, Aberegg SK, Marsh CB etal. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 2007; 35: 345-50.
25. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198: 336-43.
26. McDonald E, Bailie R, Brewster D, Morris P. Are hygiene and public health interventions likely to improve outcomes for Australian Aboriginal children living in remote communities? A systematic review of the literature. BMC Public Health 2008; 8: 153.
27. McDonald E, Bailie R, Grace J, Brewster D. A case study of physical and social barriers to hygiene and child growth in remote Australian Aboriginal communities. BMC Public Health 2009; 9: 346.
28. Bailie RS, Runcie MJ. Household infrastructure in aboriginal communities and the implications for health improvement. Med J Aust 2001; 175: 363-6.
29. Turnidge JD. High burden of staphylococcal disease in indigenous communities. J Infect Dis 2009; 199: 1416-8.
30. Hengge UR, Currie BJ, Jager G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006; 6: 769-79.
31. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25: 181-5.
32. Spellberg B, Talbot GH, Boucher HW, Bradley JS, Gilbert D, Scheld WM etal. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis 2009; 49: 383-91.
33. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685-94.
34. Collignon PJ, Cruickshank M. Staphylococcus aureus bacteraemias: time to act. Med J Aust 2009; 191: 363-4.